Our Co-founder, Crawford Hollingworth recently gave a talk and chaired a panel discussion at the annual EphMRA (European Pharmaceutical Market Research Association) conference.
In the talk, Crawford shared how Behavioural Science inspired interventions can tackle inertia and drive real behaviour change - drawing on examples from work TBA had done in international aid, diabetes and oral health.
Then in a panel discussion, he was joined by three senior industry clients from Eli Lilly, GSK and NCIMI, who shared their personal journeys into applied Behavioural Science and how it is being used within their organisations to add new value and impact. A discussion followed about where Behavioural Science is going and how to unlock further power within organisations. This was a truly open and inspiring discussion from three very different perspectives.
If you would like to hear more about these two sessions, then please contact us for more details.